Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for animal healthcare. The report offers a detailed assessment of key market dynamics, encompassing drivers, trends, opportunities, and challenges, providing in-depth insights into the market structure. This research publication provides exclusive data and statistics outlining the anticipated growth trajectory of the global animal healthcare market from 2024 to 2033.

Key Insights:

• Animal Healthcare Market Size (2024E): USD 42.3 Billion
• Projected Market Value (2033F): USD 60.3 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 4.0%

Animal Healthcare Market - Report Scope:

The animal healthcare market encompasses products and services aimed at enhancing the health and well-being of animals across various species, including pets, livestock, and companion animals. This market caters to veterinary clinics, hospitals, animal welfare organizations, and pet owners, offering a range of pharmaceuticals, vaccines, diagnostics, and healthcare services.

Market Growth Drivers:

The global animal healthcare market is driven by several factors, including increasing pet ownership rates, rising demand for protein-rich diets necessitating better livestock health management, and growing awareness about preventive veterinary care. Advances in veterinary pharmaceuticals, biotechnology, and diagnostics are enhancing treatment outcomes and expanding the scope of care across diverse animal species. Moreover, regulatory initiatives promoting animal welfare and healthcare standards are bolstering market growth.

Market Restraints:

Despite favorable growth prospects, the animal healthcare market faces challenges related to regulatory compliance, pricing pressures, and the complexity of disease management in diverse animal populations. Stringent regulations governing the approval and commercialization of veterinary drugs and vaccines impose significant hurdles on market entry and product development. Additionally, economic volatility and fluctuations in livestock prices impact healthcare expenditures in the agricultural sector, influencing market dynamics.

Market Opportunities:

The animal healthcare market presents significant growth opportunities driven by technological innovations, demographic shifts, and evolving consumer preferences toward premium pet care products. The integration of digital health technologies, such as telemedicine and remote monitoring platforms, enhances veterinary care accessibility and client engagement. Furthermore, the expanding role of personalized medicine in veterinary diagnostics and therapeutics fosters innovation and market expansion. Strategic partnerships, investment in research and development, and the introduction of cost-effective healthcare solutions tailored to different animal species are crucial to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the animal healthcare market globally?
• Which segments and species are driving adoption of animal healthcare products and services?
• How are technological advancements reshaping the competitive landscape of the animal healthcare market?
• Who are the key players contributing to the animal healthcare market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global animal healthcare market?

Competitive Intelligence and Business Strategy:

Leading players in the global animal healthcare market, including Zoetis Inc., Merck Animal Health, and Elanco Animal Health, focus on innovation, regulatory compliance, and strategic acquisitions to gain a competitive edge. These companies invest in R&D to develop novel pharmaceuticals, vaccines, and diagnostic solutions, addressing diverse veterinary needs and market demands. Collaborations with veterinary clinics, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on veterinary education, disease prevention, and sustainable healthcare practices supports market growth and enhances animal health outcomes in the dynamic animal healthcare landscape.

Key Companies Profiled:

• Bayer AG
• Boehringer Ingelheim GmbH
• Virbac SA
• Zoetis, Inc.
• Hester Biosciences Ltd.
• Intas Pharmaceuticals Ltd
• Merck Animal Health
• Elanco (Eli Lilly and Company)
• Ceva Santé Animale
• Alivira Animal Health Limited
• Vetoquinol S.A.
• Zydus Animal Health
• Norbrook Laboratories Limited
• Phibro Animal Health Corporation
• Dechra Pharmaceuticals PLC
• Norbrook Laboratories, Inc

Key Segments Covered in Global Industry Research

Drugs:
• Anti-Infective Agents
• Antibiotics & Antimicrobials
• Parasiticides
• Vaccines
• Hormones & Substitutes
• Nutritional Products

Animals:
• Companion Animals
• Farm Animals

Route of Administration:
• Oral
• Parenteral
• Topical

Distribution Channel:
• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption Analysis
4.2. Key Regulations
4.3. Disease Epidemiology
4.4. Key Industry Developments
4.5. PESTEL Analysis
4.6. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Veterinary Services Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Trend of Pet Adoption
5.2.2. Cost Associated with Veterinary Medications
5.2.3. Introduction of Regulatory Policies
5.2.4. Growing Prevalence of Zoonotic Diseases
5.2.5. Increasing Demand for Animal Sourced Products
5.2.6. Rising Global Consumption of Meat
5.2.7. Surge in Animal Care Expenditure
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Drug
6.1.2. By Animal
6.1.3. By Route of Administration
6.1.4. By Distribution Channel
6.1.5. By Country
6.2. 2024 Market Scenario
7. Global Animal Healthcare Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Drug
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Drug, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Drug, 2024-2033
8.3.1. Anti-Infective Agents
8.3.1.1. Antibiotics & Antimicrobials
8.3.1.2. Anti-Fungal
8.3.1.3. Anti-Viral
8.3.2. Anti-Inflammatory & Analgesic Agents
8.3.3. Parasiticides
8.3.3.1. Endo-Parasiticides
8.3.3.2. Ecto-Parasiticides
8.3.3.3. Endectocides
8.3.4. Vaccines
8.3.5. Hormones & Substitutes
8.3.6. Nutritional Products
8.3.7. Others
8.4. Market Attractiveness Analysis By Drug
9. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Animal
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis, By Animal, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Animal, 2024-2033
9.3.1. Companion Animals
9.3.1.1. Cats
9.3.1.2. Dogs
9.3.1.3. Horse
9.3.2. Farm Animals
9.3.2.1. Ruminants
9.3.2.2. Swine
9.3.2.3. Poultry
9.4. Market Attractiveness Analysis By Animal
10. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Route of Administration
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Route of Administration, 2024-2033
10.3.1. Oral
10.3.1.1. Tablets/Capsules
10.3.1.2. Liquids
10.3.1.3. Powders/Premix
10.3.1.4. Others
10.3.2. Parenteral
10.3.2.1. Liquids
10.3.2.2. Powder for Injection
10.3.3. Topical
10.3.3.1. Solutions (Spot-on, Pour-on)
10.3.3.2. Creams & Ointments
10.3.3.3. Intramammary Preparations
10.3.3.4. Others
10.3.4. Others
10.4. Market Attractiveness Analysis By Route of Administration
11. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channel, 2024-2033
11.3.1. Veterinary Hospitals
11.3.2. Veterinary Clinics
11.3.3. Pharmacies & Drug Stores
11.3.4. Others
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, By Region, 2024-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Drug
13.3.3. By Animal
13.3.4. By Route of Administration
13.3.5. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Drug
13.4.3. By Animal
13.4.4. By Route of Administration
13.4.5. By Distribution Channel
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Key Players - Intensity Mapping
13.8. Country Level Analysis & Forecast
13.8.1. U.S. Animal Healthcare Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Drug
13.8.1.2.2. By Animal
13.8.1.2.3. By Route of Administration
13.8.1.2.4. By Distribution Channel
13.8.2. Canada Animal Healthcare Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Drug
13.8.2.2.2. By Animal
13.8.2.2.3. By Route of Administration
13.8.2.2.4. By Distribution Channel
14. Latin America Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Mexico
14.3.1.2. Brazil
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Drug
14.3.3. By Animal
14.3.4. By Route of Administration
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug
14.4.3. By Animal
14.4.4. By Route of Administration
14.4.5. By Distribution Channel
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
14.8.1. Mexico Animal Healthcare Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Drug
14.8.1.2.2. By Animal
14.8.1.2.3. By Route of Administration
14.8.1.2.4. By Distribution Channel
14.8.2. Brazil Animal Healthcare Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Drug
14.8.2.2.2. By Animal
14.8.2.2.3. By Route of Administration
14.8.2.2.4. By Distribution Channel
14.8.3. Argentina Animal Healthcare Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Drug
14.8.3.2.2. By Animal
14.8.3.2.3. By Route of Administration
14.8.3.2.4. By Distribution Channel
15. Europe Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Drug
15.3.3. By Animal
15.3.4. By Route of Administration
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug
15.4.3. By Animal
15.4.4. By Route of Administration
15.4.5. By Distribution Channel
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
15.8.1. Germany Animal Healthcare Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Drug
15.8.1.2.2. By Animal
15.8.1.2.3. By Route of Administration
15.8.1.2.4. By Distribution Channel
15.8.2. Italy Animal Healthcare Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Drug
15.8.2.2.2. By Animal
15.8.2.2.3. By Route of Administration
15.8.2.2.4. By Distribution Channel
15.8.3. France Animal Healthcare Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Drug
15.8.3.2.2. By Animal
15.8.3.2.3. By Route of Administration
15.8.3.2.4. By Distribution Channel
15.8.4. U.K. Animal Healthcare Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Drug
15.8.4.2.2. By Animal
15.8.4.2.3. By Route of Administration
15.8.4.2.4. By Distribution Channel
15.8.5. Spain Animal Healthcare Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Drug
15.8.5.2.2. By Animal
15.8.5.2.3. By Route of Administration
15.8.5.2.4. By Distribution Channel
15.8.6. BENELUX Animal Healthcare Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Drug
15.8.6.2.2. By Animal
15.8.6.2.3. By Route of Administration
15.8.6.2.4. By Distribution Channel
15.8.7. Russia Animal Healthcare Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Drug
15.8.7.2.2. By Animal
15.8.7.2.3. By Route of Administration
15.8.7.2.4. By Distribution Channel
16. East Asia Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Drug
16.3.3. By Animal
16.3.4. By Route of Administration
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug
16.4.3. By Animal
16.4.4. By Route of Administration
16.4.5. By Distribution Channel
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
16.8.1. China Animal Healthcare Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Drug
16.8.1.2.2. By Animal
16.8.1.2.3. By Route of Administration
16.8.1.2.4. By Distribution Channel
16.8.2. Japan Animal Healthcare Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Drug
16.8.2.2.2. By Animal
16.8.2.2.3. By Route of Administration
16.8.2.2.4. By Distribution Channel
16.8.3. South Korea Animal Healthcare Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Drug
16.8.3.2.2. By Animal
16.8.3.2.3. By Route of Administration
16.8.3.2.4. By Distribution Channel
17. South Asia Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Drug
17.3.3. By Animal
17.3.4. By Route of Administration
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Drug
17.4.3. By Animal
17.4.4. By Route of Administration
17.4.5. By Distribution Channel
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players - Intensity Mapping
17.8. Country Level Analysis & Forecast
17.8.1. India Animal Healthcare Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Drug
17.8.1.2.2. By Animal
17.8.1.2.3. By Route of Administration
17.8.1.2.4. By Distribution Channel
17.8.2. Indonesia Animal Healthcare Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Drug
17.8.2.2.2. By Animal
17.8.2.2.3. By Route of Administration
17.8.2.2.4. By Distribution Channel
17.8.3. Malaysia Animal Healthcare Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Drug
17.8.3.2.2. By Animal
17.8.3.2.3. By Route of Administration
17.8.3.2.4. By Distribution Channel
17.8.4. Thailand Animal Healthcare Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Drug
17.8.4.2.2. By Animal
17.8.4.2.3. By Route of Administration
17.8.4.2.4. By Distribution Channel
18. Oceania Animal Healthcare Market 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Drug
18.3.3. By Animal
18.3.4. By Route of Administration
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Drug
18.4.3. By Animal
18.4.4. By Route of Administration
18.4.5. By Distribution Channel
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Players - Intensity Mapping
18.8. Country Level Analysis & Forecast
18.8.1. Australia Animal Healthcare Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Drug
18.8.1.2.2. By Animal
18.8.1.2.3. By Route of Administration
18.8.1.2.4. By Distribution Channel
18.8.2. New Zealand Animal Healthcare Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Drug
18.8.2.2.2. By Animal
18.8.2.2.3. By Route of Administration
18.8.2.2.4. By Distribution Channel
19. Middle East and Africa (MEA) Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. North Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Drug
19.3.3. By Animal
19.3.4. By Route of Administration
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Drug
19.4.3. By Animal
19.4.4. By Route of Administration
19.4.5. By Distribution Channel
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Key Players - Intensity Mapping
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Animal Healthcare Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Drug
19.8.1.2.2. By Animal
19.8.1.2.3. By Route of Administration
19.8.1.2.4. By Distribution Channel
19.8.2. Turkey Animal Healthcare Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Drug
19.8.2.2.2. By Animal
19.8.2.2.3. By Route of Administration
19.8.2.2.4. By Distribution Channel
19.8.3. South Africa Animal Healthcare Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Drug
19.8.3.2.2. By Animal
19.8.3.2.3. By Route of Administration
19.8.3.2.4. By Distribution Channel
19.8.4. North Africa Animal Healthcare Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Drug
19.8.4.2.2. By Animal
19.8.4.2.3. By Route of Administration
19.8.4.2.4. By Distribution Channel
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Bayer AG
21.3.1.1. Overview
21.3.1.2. Drug Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Key Financials
21.3.1.5. SWOT Analysis
21.3.1.6. Strategy Overview
21.3.1.6.1. Marketing Strategy
21.3.1.6.2. Product Strategy
21.3.1.6.3. Channel Strategy
21.3.2. Boehringer Ingelheim GmbH
21.3.2.1. Overview
21.3.2.2. Drug Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Key Financials
21.3.2.5. SWOT Analysis
21.3.2.6. Strategy Overview
21.3.2.6.1. Marketing Strategy
21.3.2.6.2. Product Strategy
21.3.2.6.3. Channel Strategy
21.3.3. Virbac SA
21.3.3.1. Overview
21.3.3.2. Drug Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Key Financials
21.3.3.5. SWOT Analysis
21.3.3.6. Strategy Overview
21.3.3.6.1. Marketing Strategy
21.3.3.6.2. Product Strategy
21.3.3.6.3. Channel Strategy
21.3.4. Zoetis, Inc.
21.3.4.1. Overview
21.3.4.2. Drug Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Key Financials
21.3.4.5. SWOT Analysis
21.3.4.6. Strategy Overview
21.3.4.6.1. Marketing Strategy
21.3.4.6.2. Product Strategy
21.3.4.6.3. Channel Strategy
21.3.5. Hester Biosciences Ltd.
21.3.5.1. Overview
21.3.5.2. Drug Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Key Financials
21.3.5.5. SWOT Analysis
21.3.5.6. Strategy Overview
21.3.5.6.1. Marketing Strategy
21.3.5.6.2. Product Strategy
21.3.5.6.3. Channel Strategy
21.3.6. Intas Pharmaceuticals Ltd
21.3.6.1. Overview
21.3.6.2. Drug Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Key Financials
21.3.6.5. SWOT Analysis
21.3.6.6. Strategy Overview
21.3.6.6.1. Marketing Strategy
21.3.6.6.2. Product Strategy
21.3.6.6.3. Channel Strategy
21.3.7. Merck Animal Health
21.3.7.1. Overview
21.3.7.2. Drug Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Key Financials
21.3.7.5. SWOT Analysis
21.3.7.6. Strategy Overview
21.3.7.6.1. Marketing Strategy
21.3.7.6.2. Product Strategy
21.3.7.6.3. Channel Strategy
21.3.8. Elanco (Eli Lilly and Company)
21.3.8.1. Overview
21.3.8.2. Drug Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Key Financials
21.3.8.5. SWOT Analysis
21.3.8.6. Strategy Overview
21.3.8.6.1. Marketing Strategy
21.3.8.6.2. Product Strategy
21.3.8.6.3. Channel Strategy
21.3.9. Ceva Santé Animale
21.3.9.1. Overview
21.3.9.2. Drug Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Key Financials
21.3.9.5. SWOT Analysis
21.3.9.6. Strategy Overview
21.3.9.6.1. Marketing Strategy
21.3.9.6.2. Product Strategy
21.3.9.6.3. Channel Strategy
21.3.10. Alivira Animal Health Limited
21.3.10.1. Overview
21.3.10.2. Drug Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Key Financials
21.3.10.5. SWOT Analysis
21.3.10.6. Strategy Overview
21.3.10.6.1. Marketing Strategy
21.3.10.6.2. Product Strategy
21.3.10.6.3. Channel Strategy
21.3.11. Vetoquinol S.A.
21.3.11.1. Overview
21.3.11.2. Drug Portfolio
21.3.11.3. Sales Footprint
21.3.11.4. Key Financials
21.3.11.5. SWOT Analysis
21.3.11.6. Strategy Overview
21.3.11.6.1. Marketing Strategy
21.3.11.6.2. Product Strategy
21.3.11.6.3. Channel Strategy
21.3.12. Zydus Animal Health
21.3.12.1. Overview
21.3.12.2. Drug Portfolio
21.3.12.3. Sales Footprint
21.3.12.4. Key Financials
21.3.12.5. SWOT Analysis
21.3.12.6. Strategy Overview
21.3.12.6.1. Marketing Strategy
21.3.12.6.2. Product Strategy
21.3.12.6.3. Channel Strategy
21.3.13. Norbrook Laboratories Limited
21.3.13.1. Overview
21.3.13.2. Drug Portfolio
21.3.13.3. Sales Footprint
21.3.13.4. Key Financials
21.3.13.5. SWOT Analysis
21.3.13.6. Strategy Overview
21.3.13.6.1. Marketing Strategy
21.3.13.6.2. Product Strategy
21.3.13.6.3. Channel Strategy
21.3.14. Phibro Animal Health Corporation
21.3.14.1. Overview
21.3.14.2. Drug Portfolio
21.3.14.3. Sales Footprint
21.3.14.4. Key Financials
21.3.14.5. SWOT Analysis
21.3.14.6. Strategy Overview
21.3.14.6.1. Marketing Strategy
21.3.14.6.2. Product Strategy
21.3.14.6.3. Channel Strategy
21.3.15. Dechra Pharmaceuticals PLC
21.3.15.1. Overview
21.3.15.2. Drug Portfolio
21.3.15.3. Sales Footprint
21.3.15.4. Key Financials
21.3.15.5. SWOT Analysis
21.3.15.6. Strategy Overview
21.3.15.6.1. Marketing Strategy
21.3.15.6.2. Product Strategy
21.3.15.6.3. Channel Strategy
21.3.16. Norbrook Laboratories, Inc
21.3.16.1. Overview
21.3.16.2. Drug Portfolio
21.3.16.3. Sales Footprint
21.3.16.4. Key Financials
21.3.16.5. SWOT Analysis
21.3.16.6. Strategy Overview
21.3.16.6.1. Marketing Strategy
21.3.16.6.2. Product Strategy
21.3.16.6.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology